Movement disorders: Improved understanding of early disease

The Lancet Neurology

Volumn 12, Issue 1, 2013, Pages 10-12

  Schneider, Susanne A ^a   Obeso, José A ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; LEVODOPA;

DEGENERATIVE DISEASE; DISEASE SEVERITY; HUMAN; HUNTINGTON CHOREA; MOLECULAR GENETICS; MOTOR DYSFUNCTION; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM;

COMPREHENSION; EARLY DIAGNOSIS; HUMANS; MOVEMENT DISORDERS; PARKINSON DISEASE; TAI JI;

EID: 84870842186     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70302-2     Document Type: Note

References (11)

1. Siderowf A, Lang AE Premotor Parkinson's disease: concepts and definitions. Mov Disord 2012, 27:608-616. 15;.
2. Pouclet H, Lebouvier T, Coron E, et al. Synuclein deposits in the rectum. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol Dis 2012, 45:305-309.
3. Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord 2012, 27:716-719.
4. Del Tredici K, Braak H Lewy pathology and neurodegeneration in premotor Parkinson's disease. Mov Disord 2012, 27:597-607.
5. Olanow CW, Prusiner SB Is Parkinson's disease a prion disorder?. Proc Natl Acad Sci USA 2009, 106:12571-12572.
6. Luk KC, Kehm V, Carroll J, et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
7. Kwon DH, Kim JM, Oh SH, et al. Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol 2012, 71:267-277.
8. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012, 27:349-356.
9. Tabrizi SJ, Reilmann R, Roos RA, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 2012, 11:42-53.
10. Duncan RP, Earhart GM Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease. Neurorehabil Neural Repair 2012, 26:132-143.
11. Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med 2012, 366:511-519.